News
-
-
-
COMMUNIQUÉ DE PRESSE
EUROPEAN COMMISSION APPROVES AMGEN'S IMDYLLTRA® FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
The European Commission has approved Amgen's IMDYLLTRA as a monotherapy for treating extensive-stage small cell lung cancer with a significant survival benefit over chemotherapy -
-
-